JorgeJ.NievaMD
Oncology • Los Angeles, CAHead & Neck Cancer, Hematologic Oncology, Thoracic Cancer
Associate Professor, Medicine, Keck School of Medicine of the University of So California
Dr. Nieva is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1441 Eastlake Ave
Los Angeles, CA 90089Phone+1 800-872-2273Fax+1 323-865-0061- Is this information wrong?
Education & Training
Scripps Clinic/Scripps Green HospitalFellowship, Hematology and Medical Oncology, 2000 - 2003
University of California (San Diego) Medical CenterResidency, Internal Medicine, 1997 - 2000
University of California, Irvine, School of MedicineClass of 1997
Certifications & Licensure
CA State Medical License 1999 - 2024
MT State Medical License 2007 - 2016
WY State Medical License 2007 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Jul 08
- Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475 Start of enrollment: 2017 Mar 10
- Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma Start of enrollment: 2018 Oct 04
- Join now to see all
Publications & Presentations
PubMed
- Characterization of Thyroid Cancer among Hispanics in California, USA, from 2010 to 2020.Kai-Ya Tsai, Katherine Y Wojcik, Alice W Lee, Lihua Liu, Robert C Hsu, David J Benjamin, Krithika Chennapan, Jacob S Thomas, Jorge J Nieva> ;Cancers. 2024 Mar 8
- Influence ofComutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in-Mutant Non-Small-Cell Lung Cancer.Naqash, A., Floudas, C., Aber, E., Maoz, A., Nassar, A., Adib, E., Choucair, K., Xiu, J., Baca, Y., Ricciuti, B., Alessi, J., Awad, M., Kim, C., Judd, J., Raez, L., Lo...> ;JCO Precision Oncology. 2024 Feb 1
- Pan-tumor survey of ROS1 fusions detected by next-generation RNA and whole transcriptome sequencing.Misako Nagasaka, Yasmine Baca, Joanne Xiu, Jorge Nieva, Ari Vanderwalde, Jeffrey J Swensen, David Spetzler, Wolfgang Michael Korn, Luis E Raez, Stephen V Liu, Sai-Hong...> ;BMC Cancer. 2023 Oct 18
- Join now to see all
Press Mentions
Rising Standards in Regulatory Decisions Highlight Challenges in Drug Development in Lung CancerFebruary 7th, 2023- FDA Committee Unanimously Rejects 131-I-Omburtamab for NeuroblastomaOctober 28th, 2022
- FDA Panel Puts PI3K Inhibitors for Blood Cancers on NoticeApril 22nd, 2022
- Join now to see all
Professional Memberships
- Member
Other Languages
- Spanish
Hospital Affiliations
Huntington HealthPasadena, California
Los Angeles General Medical CenterLos Angeles, California
Keck Hospital of USCLos Angeles, California
USC Norris Comprehensive Cancer CenterLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
